APA (7th ed.) Citation

Watanabe, R., Ishii, T., Araki, K., Ishizuka, M., Kamogawa, Y., Fujita, Y., . . . Harigae, H. (2016). Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis. Modern rheumatology, 26(3), 465-466. https://doi.org/10.3109/14397595.2015.1012797

Chicago Style (17th ed.) Citation

Watanabe, Ryu, Tomonori Ishii, Kyoko Araki, Mariko Ishizuka, Yukiko Kamogawa, Yoko Fujita, Yuko Shirota, Hiroshi Fujii, and Hideo Harigae. "Successful Multi-target Therapy Using Corticosteroid, Tacrolimus, Cyclophosphamide, and Rituximab for Rapidly Progressive Interstitial Lung Disease in a Patient with Clinically Amyopathic Dermatomyositis." Modern Rheumatology 26, no. 3 (2016): 465-466. https://doi.org/10.3109/14397595.2015.1012797.

MLA (9th ed.) Citation

Watanabe, Ryu, et al. "Successful Multi-target Therapy Using Corticosteroid, Tacrolimus, Cyclophosphamide, and Rituximab for Rapidly Progressive Interstitial Lung Disease in a Patient with Clinically Amyopathic Dermatomyositis." Modern Rheumatology, vol. 26, no. 3, 2016, pp. 465-466, https://doi.org/10.3109/14397595.2015.1012797.